Indivior applies for US FDA approval for schizophrenia drug, buys rival patent rights 1 234 567

Indivior applies for US FDA approval for schizophrenia drug, buys rival patent rights

livecharts.co.uk

Indivior has submitted a new drug application in the US for a once-monthly injectable schizophrenia treatment and agreed to buy out patent rights from a manufacturer of similar antipsychotic medication.

Full news

Share:

More:

1 234 567

1 234 567

1 234 567

1 234 567

1 234 567

1 234 567